For this purpose, the impact of TSPAN1 inhibition was functionally assessed both in vitro and in vivo using disease-relevant HNSCC models, and the clinical role of TSPAN1 was also further explored in a large series of HNSCC patient samples. This evidence concerns the gene TSPAN1 and head and neck squamous cell carcinoma.